WST - West Pharmaceutical Services, Inc.

NYSE - NYSE Delayed price. Currency in USD

West Pharmaceutical Services, Inc.

530 Herman O. West Drive
Exton, PA 19341-0645
United States
610 594 2900

IndustryMedical Instruments & Supplies
Full-time employees10,700

Key executives

NameTitlePayExercisedYear born
Mr. Eric M. GreenChair, Pres & CEO1.92M9.08M1970
Mr. Bernard J. BirkettSr. VP and Chief Financial & Operations Officer985.12kN/A1969
Mr. Silji AbrahamSr. VP & Chief Technology Officer711.9kN/A1972
Ms. Kimberly Banks MacKaySr. VP, Gen. Counsel & Company Sec.850.04kN/A1966
Ms. Cindy Reiss-ClarkSr. VP & Chief Commercial Officer775.49kN/A1974
Mr. Chad R. WintersVP, Chief Accounting Officer & Corp. ControllerN/AN/A1979
Dr. Quintin J. Lai C.F.A., Ph.D.VP of Strategy & Investor RelationsN/AN/A1967
Michele PolinskyVP of Global CommunicationsN/AN/AN/A
Ms. Annette F. FavoriteChief HR Officer & Sr. VPN/AN/A1965
Mr. Christopher G. RyanSr. VP of Containment & Glass SystemsN/AN/A1961
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Corporate governance

West Pharmaceutical Services, Inc.’s ISS governance QualityScore as of 1 May 2023 is 6. The pillar scores are Audit: 3; Board: 9; Shareholder rights: 8; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.